|
|
Components
| ACADIA Pharmaceuticals Inc. |
ACAD |
| Alkermes Plc |
ALKS |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
| Amgen Inc. |
AMGN |
| argenx SE (ADR) |
ARGX |
| BeiGene, Ltd. (ADR) |
BGNE |
| Biogen Inc. |
BIIB |
| BioMarin Pharmaceutical Inc. |
BMRN |
| BioNTech SE (ADR) |
BNTX |
| Bruker Corporation |
BRKR |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
| Corcept Therapeutics Incorporated |
CORT |
| Exact Sciences Corporation |
EXAS |
| Exelixis, Inc. |
EXEL |
| Genmab A/S (ADR) |
GMAB |
| Gilead Sciences, Inc. |
GILD |
| Halozyme Therapeutics, Inc. |
HALO |
| Illumina, Inc. |
ILMN |
| Incyte Corporation |
INCY |
| Intra-Cellular Therapies, Inc. |
ITCI |
| Mettler-Toledo International Inc. |
MTD |
| Moderna, Inc. |
MRNA |
| Natera, Inc. |
NTRA |
| Neurocrine Biosciences, Inc. |
NBIX |
| Regeneron Pharmaceuticals, Inc. |
REGN |
| Repligen Corporation |
RGEN |
| Sarepta Therapeutics, Inc. |
SRPT |
| United Therapeutics Corporation |
UTHR |
| Vertex Pharmaceuticals Incorporated |
VRTX |
| Waters Corporation |
WAT |
|
|
|
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|